Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.

Pharmacogenetics and genomics - 1 Feb 2009

Liu Yongjun, Ordovas Jose M, Gao Guimin, Province Michael, Straka Robert J, Tsai Michael Y, Lai Chao-Qiang, Zhang Kui, Borecki Ingrid, Hixson James E, Allison David B, Arnett Donna K

Abstract excerpt

BACKGROUND: The apolipoproteins (APOA1/C3/A4/A5) are key components in modulating lipoprotein metabolism. It is unknown whether variants at the APOA1/C3/A4/A5 gene cluster are associated with lipid response to pharmacologic intervention. METHODS AND RESULTS: Plasma triglycerides (TGs) and high-de...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-I
Share to Apolipoprotein A-V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein C-III

Share to Apolipoproteins

Share to Apolipoproteins A

Share to Hypertriglyceridemia

Share to Hypolipidemic Agents

Source

Open in PubMed Open full text

Identifiers

PMID: 19057464
DOI: 10.1097/FPC.0b013e32831e030e
PMCID: PMC2733171

Genes

APOA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19057464-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.PMID 19057464Read ↗

Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate.Semantic proximity Read ↗

Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.Semantic proximity Read ↗

The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate.Semantic proximity Read ↗

Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.Semantic proximity Read ↗

The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment.Semantic proximity Read ↗

Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.Semantic proximity Read ↗

APOA1/C3/A4/A5 Gene Cluster at 11q23.3 and Lipid Metabolism Disorders: From Epigenetic Mechanisms to Clinical PracticesSemantic proximity Read ↗

Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy.Semantic proximity Read ↗

Effects of apolipoprotein A5 haplotypes on the ratio of triglyceride to high-density lipoprotein cholesterol and the risk for metabolic syndrome in Koreans.Semantic proximity Read ↗

Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.Semantic proximity Read ↗

Differential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region.Semantic proximity Read ↗

The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.